Affigen's Series A Round

Affigen raised a round of funding on February 21, 2017. Investors include Black Beret Life Sciences.

Affigen is a biotechnology company that develops tumor-identifying therapeutics that target cell lineage-specific tumor proteins in certain incurable cancers.…

Articles about Affigen's Series A Round: